Home Newsfeeds JP Morgan Maintains Overweight on Oracle, Raises Price Target to $84

JP Morgan Maintains Overweight on Oracle, Raises Price Target to $84

JP Morgan analyst Mark Murphy maintains Oracle (NYSE:ORCL) with a Overweight and raises the price target from $82 to $84.

byBenzinga Newsdesk

September 13, 2022

1 minute read

JP Morgan analyst Mark Murphy maintains Oracle (NYSE:ORCL) with a Overweight and raises the price target from $82 to $84.

Global
News

Constl, Selects Ciena Optical Technology To Offer High-Capacity Digital Connectivity In India

By Benzinga Newsdesk

June 3, 9:08 AM

Ciena technology being deployed across Constl's multiple metros and pan-India NLD networksConstl, a subsidiary of Space World Group, is deploying Ciena's (NYSE:CIEN) optical technology to offer high speed Metro Area

CIEN

Here’s How Much $100 Invested In Nike 15 Years Ago Would Be Worth Today

By Benzinga Insights

August 2, 5:02 PM

Nike (NYSE:NKE) has outperformed the market over the past 15 years by 7.86% on an annualized basis producing an average annual return of 14.77%. Currently, Nike has a market capitalization of $175.27 billion.

NKE

Why is Cancer-Focused Kinnate Biopharma Stock Trading Higher Today?

By Vandana Singh

November 15, 11:02 AM

Kinnate Biopharma Inc's (NASDAQ: KNTE) board of directors received a letter from Foresite Capital Management and OrbiMed Advisors indicating their intent to explore and evaluate a potential acquisition of the company.

KNTE

Axalta Coating Systems Sees Q3 EPS $0.35-$0.40 Vs $0.42 Est.; FY23 EPS $1.40-$1.45 Vs $1.57 Est.

By Happy Mohamed

August 1, 4:24 PM

Q3 2023 Outlook: (in millions, except per share data & %s) Projection Net Sales growth versus Q3 2022 (FX benefit) 3-5% (~3%) Adjusted EBIT (Adjusted

AXTA

JP Morgan Maintains Overweight on Oracle, Raises Price Target to $84

Related Posts

Constl, Selects Ciena Optical Technology To Offer High-Capacity Digital Connectivity In India

Here’s How Much $100 Invested In Nike 15 Years Ago Would Be Worth Today

Why is Cancer-Focused Kinnate Biopharma Stock Trading Higher Today?

Axalta Coating Systems Sees Q3 EPS $0.35-$0.40 Vs $0.42 Est.; FY23 EPS $1.40-$1.45 Vs $1.57 Est.